Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating T Helper-1 Adaptive Immunity
Author(s) -
Ingo Hilgendorf,
Igor Theurl,
Louisa M.S. Gerhardt,
Clinton S. Robbins,
Georg F. Weber,
Ayelet Gonen,
Yoshiko Iwamoto,
Norbert Degousée,
Tobias A.W. Holderried,
Carla Winter,
Andreas Zirlik,
Herbert Y. Lin,
Galina K. Sukhova,
Jagdish Butany,
Barry B. Rubin,
Joseph L. Witztum,
Peter Libby,
Matthias Nahrendorf,
Ralph Weissleder,
Filip K. Świrski
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.006381
Subject(s) - immunology , acquired immune system , chemokine , immune system , macrophage , cd40 , population , innate immune system , b cell , microbiology and biotechnology , antigen presenting cell , medicine , biology , t cell , antibody , cytotoxic t cell , in vitro , biochemistry , environmental health
Atherosclerotic lesions grow via the accumulation of leukocytes and oxidized lipoproteins in the vessel wall. Leukocytes can attenuate or augment atherosclerosis through the release of cytokines, chemokines, and other mediators. Deciphering how leukocytes develop, oppose, and complement each other's function and shape the course of disease can illuminate our understanding of atherosclerosis. Innate response activator (IRA) B cells are a recently described population of granulocyte macrophage colony-stimulating factor-secreting cells of hitherto unknown function in atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom